Cargando…
Towards automated manufacturing of clinical scale gene-modified T cells
Autores principales: | Drechsel, Katharina, Mauer, Daniela, Mockel-Tenbrinck, Nadine, Lehmann, Constanze, Bohnenkamp, Hermann, Huppert, Volker, Assenmacher, Mario, Johnston, Ian, Kaiser, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288587/ http://dx.doi.org/10.1186/2051-1426-2-S3-P21 |
Ejemplares similares
-
Automated Enrichment, Transduction, and Expansion of Clinical-Scale CD62L(+) T Cells for Manufacturing of Gene Therapy Medicinal Products
por: Priesner, Christoph, et al.
Publicado: (2016) -
Towards a commercial process for the manufacture of genetically modified T cells for therapy
por: Kaiser, A D, et al.
Publicado: (2015) -
Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing
por: Radek, Constanze, et al.
Publicado: (2019) -
A Novel Siglec-4 Derived Spacer Improves the Functionality of CAR T Cells Against Membrane-Proximal Epitopes
por: Schäfer, Daniel, et al.
Publicado: (2020) -
Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering
por: Oberschmidt, Olaf, et al.
Publicado: (2019)